121 related articles for article (PubMed ID: 9157179)
1. Release of Type II phospholipase A2 immunoreactivity and phospholipase A2 enzymatic activity from human placenta.
Farrugia W; Rice GE; Wong MH; Scott KF; Brennecke SP
J Endocrinol; 1997 Apr; 153(1):151-7. PubMed ID: 9157179
[TBL] [Abstract][Full Text] [Related]
2. Contribution of type II phospholipase A2 to in vitro phospholipase A2 enzymatic activity in human term placenta.
Rice GE; Wong MH; Farrugia W; Scott KF
J Endocrinol; 1998 Apr; 157(1):25-31. PubMed ID: 9614354
[TBL] [Abstract][Full Text] [Related]
3. Effect of bacterial endotoxin on the in vitro release of Type II phospholipase-A2 and prostaglandin E2 from human placenta.
Farrugia W; Nicholls L; Rice GE
J Endocrinol; 1999 Feb; 160(2):291-6. PubMed ID: 9924199
[TBL] [Abstract][Full Text] [Related]
4. Type II phospholipase A2 in human gestational tissues: extractable immuno- and enzymatic activity in fetal membranes.
Aitken MA; Farrugia W; Wong MH; Scott KF; Brennecke SP; Rice GE
Biochim Biophys Acta; 1993 Nov; 1170(3):314-20. PubMed ID: 8218351
[TBL] [Abstract][Full Text] [Related]
5. Secretory type II PLA2 immunoreactivity and PLA2 enzymatic activity in human gestational tissues before, during and after spontaneous-onset labour at term.
Munns MJ; Farrugia W; King RG; Rice GE
Placenta; 1999 Jan; 20(1):21-6. PubMed ID: 9950141
[TBL] [Abstract][Full Text] [Related]
6. Contribution of type II PLA2 to prostaglandin formation: a study using a type II PLA2 specific inhibitor SB 203347.
Munns MJ; King RG; Rice GE
Prostaglandins Other Lipid Mediat; 1999 Jul; 57(5-6):361-70. PubMed ID: 10480490
[TBL] [Abstract][Full Text] [Related]
7. Bacterial endotoxin increases type II phospholipase A2 immunoreactive content and phospholipase A2 enzymatic activity in human choriodecidua.
Nguyen HT; Rice GE; Farrugia W; Wong M; Brennecke SP
Biol Reprod; 1994 Mar; 50(3):526-34. PubMed ID: 8167224
[TBL] [Abstract][Full Text] [Related]
8. Type II phospholipase A2 in human gestational tissues: subcellular distribution of placental immuno- and catalytic activity.
Farrugia W; Aitken MA; van Dunné F; Wong MH; Brennecke SP; Scott KF; Rice GE
Biochim Biophys Acta; 1993 Feb; 1166(1):77-83. PubMed ID: 8431495
[TBL] [Abstract][Full Text] [Related]
9. Localization of type II phospholipase A2 messenger RNA and immunoactivity in human placenta and fetal membranes.
Aitken MA; Thomas T; Brennecke SP; Scott KF; Rice GE
Placenta; 1996 Sep; 17(7):423-9. PubMed ID: 8899871
[TBL] [Abstract][Full Text] [Related]
10. Antisense oligonucleotide inhibition of type II phospholipase A2 expression, release and activity in vitro.
Lappas M; Munns MJ; King RG; Rice GE
Placenta; 2001 May; 22(5):418-24. PubMed ID: 11373152
[TBL] [Abstract][Full Text] [Related]
11. Secretory type II phospholipase A2 and the generation of intrauterine signals.
Rice GE
Reprod Fertil Dev; 1995; 7(6):1471-9. PubMed ID: 8743149
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of type II, IV and cytosolic PLA2 messenger RNA in human intrauterine tissues at term.
Freed KA; Moses EK; Brennecke SP; Rice GE
Mol Hum Reprod; 1997 Jun; 3(6):493-9. PubMed ID: 9239738
[TBL] [Abstract][Full Text] [Related]
13. Relative abundance of human placental phospholipase A2 messenger RNA in late pregnancy.
Aitken MA; Rice G; Brennecke S
Prostaglandins; 1992 Apr; 43(4):361-70. PubMed ID: 1376934
[TBL] [Abstract][Full Text] [Related]
14. Reduction of human recombinant type II phospholipase A2 and prostaglandin F2 alpha release by microtubule depolymerizing agents.
Munns MJ; King RG; Rice GE
Clin Exp Pharmacol Physiol; 1999 Mar; 26(3):230-5. PubMed ID: 10081619
[TBL] [Abstract][Full Text] [Related]
15. Membranes exert indirect negative control on phospholipase A2 in human placenta.
Buhl WJ; Zipfel M; Garcia MT; Eisenlohr LM; Gehring U
Eicosanoids; 1991; 4(4):235-44. PubMed ID: 1790000
[TBL] [Abstract][Full Text] [Related]
16. Regulation of prostaglandin F2alpha by the specific inhibition of secretory type II phospholipase A2: implications for the management of premature labour.
Munns MJ; King RG; Rice GE
Gynecol Obstet Invest; 1999; 48(1):22-7. PubMed ID: 10394087
[TBL] [Abstract][Full Text] [Related]
17. Secretory phospholipases and membrane polishing.
Rice GE
Placenta; 1998 Jan; 19(1):13-20. PubMed ID: 9481780
[TBL] [Abstract][Full Text] [Related]
18. Type II phospholipase A2 in preterm human gestational tissues.
Lappas M; Permezel M; Georgiou HM; Rice GE
Placenta; 2001 Jan; 22(1):64-9. PubMed ID: 11162354
[TBL] [Abstract][Full Text] [Related]
19. Activation of cytosolic phospholipase A2 in permeabilized human neutrophils.
Bauldry SA; Wooten RE; Bass DA
Biochim Biophys Acta; 1996 Jan; 1299(2):223-34. PubMed ID: 8555268
[TBL] [Abstract][Full Text] [Related]
20. Regulation of phospholipase isozymes by nuclear factor-kappaB in human gestational tissues in vitro.
Lappas M; Permezel M; Georgiou HM; Rice GE
J Clin Endocrinol Metab; 2004 May; 89(5):2365-72. PubMed ID: 15126565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
